2nd Biosimilar Market Access and Commercialization Strategies Summit

Date: 17-Sep-18 to 18-Sep-18
Location: Revere Hotel Boston Common / Boston / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

The process of developing a biosimilar and bringing it to market can be a lengthy, expensive process. It is crucial for sponsor organizations to understand the policies that are currently set in order to develop strategies to allow biosimilar drugs to access the marketplace. With a limited number of biosimilars available competition is at an all-time high. However, once you gain approval the real challenge becomes sustaining market success. There is a significant market opportunity ahead for biosimilar developers if they can figure out a strategic plan to enhance the commercialization of the biosimilar.

Whether you are exploring your chances of tapping into the competitive biosimilars marketplace or are an expert in the field, the 2nd Biosimilar Market Access and Commercialization Strategies Summit will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.

Our talented faculty will address everything from navigating evolving regulations, analyzing optimal pricing models, accelerating market access strategies, and executing strategic decisions to mitigate risk and build for commercial success. Also designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.


Jay Brown, Sr. Director Outpatient Pharmacy Services, NOVANT HEALTH, INC, Niraj Chhaya, Risk Management, Biosimilars, BOEHRINGER INGELHEIM LIMITED, Mona Chitre, Vice President of Pharmacy, EXCELLUS BLUECROSS BLUESHIELD, Christopher Colburn, Director Federal Accounts — Biosimilar Products, PFIZER INCORPORATED, Ruediger Jankowsky, Managing Director, CINFA BIOTECH, Divya Chadha Manek, Head, Business Development, NIHR, Bruce Leicher, Senior Vice President and General Counsel, MOMENTA PHARMACEUTICALS, Joanna Brougher, Adjunct Professor, CORNELL LAW SCHOOL, Sarfaraz Niazi, Adjunct Professor, Department of Biopharmaceutical Sciences, UNIVERSITY OF ILLINOIS AT CHICAGO, COLLEGE OF PHARMACY, Aaron Hakim, Researcher, YALE UNIVERSITY SCHOOL OF MEDICINE, Joseph P. Fuhr, Ph.D., Adjunct Faculty College of Population Health and Professor Emeritus Economics, WIDENER UNIVERSITY, Nacer Hedroug, Associate Director Validation and Tech Transfer, WOCKHARDT LTD.

Go to event website